ABCG1 and infection: GW9662 treatment significantly promoted lipid accumulation in H37Ra-infected group and Lv-ctl group, while Lv-ABCG1 reversed the promoting effect of GW9662 on lipid accumulation in H37Ra infection group and Lv-ctl group (Figure 3B).